KAHR MEDICAL
KAHR Medical ("KAHR") is pioneering the development of "third generation biological drugs," a unique class of proprietary fusion-protein molecules with clear and far-reaching advantages. KAHR's technology represents a paradigm shift in protein-based pharmaceuticals that will significantly expand available treatment options for cancer and autoimmune disorders.
KAHR MEDICAL
Social Links:
Industry:
Biotechnology Medical Pharmaceutical
Founded:
2005-01-01
Address:
Jerusalem, Yerushalayim, Israel
Country:
Israel
Website Url:
http://www.kahr-medical.com
Total Employee:
1+
Status:
Closed
Contact:
97246392752
Email Addresses:
[email protected]
Total Funding:
88.95 M USD
Technology used in webpage:
Domain Not Resolving
Current Advisors List
Current Employees Featured
Founder
Investors List
Dafna Capital Management
Dafna Capital Management investment in Venture Round - KAHR medical
Oriella Ltd.
Oriella Ltd. investment in Venture Round - KAHR medical
Pavilion Capital
Pavilion Capital investment in Venture Round - KAHR medical
Mirae Asset Venture Investment
Mirae Asset Venture Investment investment in Venture Round - KAHR medical
Shavit Capital
Shavit Capital investment in Venture Round - KAHR medical
Cancer Focus Fund
Cancer Focus Fund investment in Venture Round - KAHR medical
Peregrine Ventures
Peregrine Ventures investment in Venture Round - KAHR medical
Flerie Invest
Flerie Invest investment in Venture Round - KAHR medical
BVF Partners
BVF Partners investment in Venture Round - KAHR medical
HBL Hadasit Bio Holdings
HBL Hadasit Bio Holdings investment in Venture Round - KAHR medical
More informations about "KAHR medical"
KAHR
SITE IS CURRENTLY BEING UPGRADED For more information see our investor presentation Contact us at: [email protected]See details»
KAHR medical - Crunchbase Company Profile & Funding
KAHR Medical ("KAHR") is pioneering the development of "third generation biological drugs," a unique class of proprietary fusion-protein molecules with clear and far-reaching advantages. …See details»
KAHR-Medical Ltd. - LinkedIn
KAHR-Medical Ltd. | 1,061 followers on LinkedIn. KAHR Medical is developing an innovative and novel drug platform of immunotherapeutic bi-functional fusion proteins that harness the human …See details»
UNMASKING CANCER CELL CAMOUFLAGE - KAHR
3 Company Highlights •Experienced leadership and executive team with track record of success •Supported by leading scientific and clinical advisory board •Raised ~$110 million to date …See details»
KAHR medical - Funding, Financials, Valuation & Investors
KAHR Medical develops novel fusion protein pharmaceuticals for the treatment of cancer and autoimmune diseases. New. Resources. Advanced Search. Start Free Trial . ... How much …See details»
KAHR - 2025 Company Profile, Funding & Competitors - Tracxn
May 31, 2025 KAHR is a series D company based in Jerusalem (Israel), founded in 2005. It operates as a Developer of immune therapeutics to treat cancer. KAHR has raised $58.5M in …See details»
Kahr medical - Craft
Kahr medical is a company that develops a novel drug platform designed to offer immuno-oncology therapies. Its platform uses the Dual Signaling Proteins (DSP) technology for the …See details»
Kahr Medical Ltd. - Shavit Capital
Kahr develops proteins that, in contrast to normal therapies, address more than one active element in a cancer cell. This technology allows to target the cancerous cell and not affect …See details»
KAHR Medical Ltd - Company Profile and News - Bloomberg …
KAHR Medical Ltd operates as a biopharmaceutical company. The Company develops drug platform based on bi-functional and immunotherapeutic fusion proteins for the treatment of …See details»
KAHR medical - Company Profile | ConnectFlux
KAHR Medical ("KAHR") is pioneering the development of "third generation biological drugs," a unique class of proprietary fusion-protein molecules with clear and far-reaching advantages. …See details»
KAHR Medical - Israeli Startup | Startup Nation Finder
Feb 17, 2022 KAHR Medical Overview KAHR is developing immuno-oncology drug candidates for the treatment of multiple types of cancer. Its lead product, DSP107, is a CD47x41BB …See details»
Kahr Medical (Israel) Funding: $101.5M - Medical Startups
KAHR Medical develops novel fusion protein pharmaceuticals for the treatment of cancer and autoimmune... Menu BY DISEASE BY TECHNOLOGY BY COUNTRY. Kahr Medical. Last …See details»
Israeli cancer treatment co KAHR Medical raises $12m
Dec 15, 2015 The Jerusalem-based company recently received regulatory approval to initiate a Phase-I/IIa trial in lymphoma treatment. Drug development company KAHR Medical Ltd has …See details»
KAHR medical - Contacts, Employees, Board Members
Organization. KAHR medical . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies ... Number of Board Member and Advisor …See details»
KAHR Medical - Overview, News & Similar companies - ZoomInfo
Mar 15, 2022 View KAHR Medical (www.kahrbio.com) location in Jerusalem, Israel , revenue, industry and description. ... 2, 2021 /PRNewswire/ -- Samsung Biologics (KRX: 207940.KS), …See details»
Kahr Medical Ltd. - BIO Investor Forum 2024
Kahr Medical Ltd. October 15, 2024 11:30 AM - 11:45 AM California Room Immunology. KAHR is a clinical stage company developing novel immune-recruiting therapies that treat cancer at the …See details»
KAHR Medical Ltd. (KAHR Medical Ltd.) - 药物管线_专利_临床试验_ …
May 7, 2025 了解KAHR Medical Ltd. (KAHR Medical Ltd.)公司的药物管线，治疗领域，技术平台，以及它的3项临床试验, 16篇新闻和10篇文献，疾病领域:肿瘤，免疫系统疾病，血液及淋巴 …See details»
KAHR Medical Careers, Perks + Culture - Built In
KAHR is a clinical stage company developing novel immune-recruiting therapies that treat cancer at the source by unleashing the synergistic power of the body’s innate and adaptive immune …See details»
Samsung Biologics and KAHR Medical Announce Development …
The agreement will streamline cell line development to IND filing process to enable seamless manufacturing of DSP502. Samsung Biologics (KRX: 207940.KS), the world’s leading contract …See details»
Kahr Medical Ltd. - BioCentury Company Profiles - BCIQ
Jun 14, 2023 Kahr Medical Ltd. - BioCentury Company Profiles for the biopharma industrySee details»